open access

Vol 52, No 4 (2021)
Review article
Submitted: 2021-07-01
Accepted: 2021-07-01
Get Citation

Anemia in children: a pediatrician’s view

Michał Matysiak1
DOI: 10.5603/AHP.2021.0075
·
Acta Haematol Pol 2021;52(4):402-405.
Affiliations
  1. Department of Oncology, Pediatric Hematology, Transplantology and Pediatrics Medical University of Warsaw, Warsaw, Poland

open access

Vol 52, No 4 (2021)
REVIEW ARTICLE
Submitted: 2021-07-01
Accepted: 2021-07-01

Abstract

Anemia is defined as a hemoglobin level that is two standard deviations below the mean for age. After children reach the age of 12, the hemoglobin norm can be further divided into gender-specific ranges. When a patient presents with anemia, it is important to establish whether the abnormality is isolated to a single cell line [red blood cells (RBC) only] or whether it is part of a multiple cell line abnormality. In children, anemia is usually caused by decreased RBC production or increased RBC turnover. Anemia is usually classified based on the size of RBC (microcytosis, normocytosis, or macrocytosis) as measured by the mean corpuscular volume. Although iron deficiency anemia is usually microcytic, some patients may have normocytic blood cells. From a practical point of view, it is better to use in children the etiologic classification of anemia which includes impaired red cell formation, blood loss and hemolytic anemia. Most children with anemia are asymptomatic, and the condition is detected on screening laboratory evaluation. Iron deficiency can be treated with oral iron, intravenous iron, and/or blood transfusion, depending on the patient`s hemoglobin levels, tolerance and co-morbidity. Oral iron salts are usually the first line of treatment for uncomplicated iron deficiency, but are poorly absorbed and lead to gastrointestinal side effects. In some cases, iron refractory iron deficiency anemia (IRIDA), a hereditary recessive anemia refractory to oral iron, occurs. IRIDA shows a slow response to intravenous iron and partial correction of anemia.

Abstract

Anemia is defined as a hemoglobin level that is two standard deviations below the mean for age. After children reach the age of 12, the hemoglobin norm can be further divided into gender-specific ranges. When a patient presents with anemia, it is important to establish whether the abnormality is isolated to a single cell line [red blood cells (RBC) only] or whether it is part of a multiple cell line abnormality. In children, anemia is usually caused by decreased RBC production or increased RBC turnover. Anemia is usually classified based on the size of RBC (microcytosis, normocytosis, or macrocytosis) as measured by the mean corpuscular volume. Although iron deficiency anemia is usually microcytic, some patients may have normocytic blood cells. From a practical point of view, it is better to use in children the etiologic classification of anemia which includes impaired red cell formation, blood loss and hemolytic anemia. Most children with anemia are asymptomatic, and the condition is detected on screening laboratory evaluation. Iron deficiency can be treated with oral iron, intravenous iron, and/or blood transfusion, depending on the patient`s hemoglobin levels, tolerance and co-morbidity. Oral iron salts are usually the first line of treatment for uncomplicated iron deficiency, but are poorly absorbed and lead to gastrointestinal side effects. In some cases, iron refractory iron deficiency anemia (IRIDA), a hereditary recessive anemia refractory to oral iron, occurs. IRIDA shows a slow response to intravenous iron and partial correction of anemia.

Get Citation

Keywords

anemia, iron deficiency, iron refractory iron deficiency anemia (IRIDA)anemia, iron deficiency, iron refractory iron deficiency anemia (IRIDA)

About this article
Title

Anemia in children: a pediatrician’s view

Journal

Acta Haematologica Polonica

Issue

Vol 52, No 4 (2021)

Article type

Review article

Pages

402-405

Page views

301

Article views/downloads

520

DOI

10.5603/AHP.2021.0075

Bibliographic record

Acta Haematol Pol 2021;52(4):402-405.

Keywords

anemia
iron deficiency
iron refractory iron deficiency anemia (IRIDA)anemia
iron deficiency
iron refractory iron deficiency anemia (IRIDA)

Authors

Michał Matysiak

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl